Company stock prices jump before public announcements of oncology trial results
Monday, September 26, 2011 - 17:30
in Mathematics & Economics
Prior knowledge of phase III clinical trials of new drugs and Food and Drug Administration (FDA) regulatory decisions may affect the price of a drug company's stock according to a new study.
